10-Q: Aemetis Q2 Loss Narrows Amid Project Progress
Quarterly Report
Aemetis, Inc. reported a narrower net loss in Q2 2025, driven by improved California Dairy RNG performance and reduced SG&A, despite significant revenue declines in other segments and ongoing liquidity concerns.
Summary
- Total revenues for the three months ended June 30, 2025, decreased by 21.5% to $52.2 million from $66.6 million in the prior year period.
- Gross loss increased by 85.8% to $3.4 million for Q2 2025, compared to $1.8 million in Q2 2024.
- Net loss for Q2 2025 narrowed to $23.4 million, an improvement from a $29.2 million net loss in Q2 2024.
- California Ethanol segment revenue decreased by 7.1% to $37.3 million, primarily due to a planned 7% decrease in ethanol sales volume (13.8 million gallons) and a 13% decrease in Wet Distillers Grains (WDG) sales volume (91 thousand tons) to optimize yields.
- California Dairy Renewable Natural Gas (RNG) segment revenue increased by 90.9% to $3.1 million, driven by increased operating digesters, with RNG sales volume up to 106.4 thousand MMBtu.
- India Biodiesel segment revenue significantly decreased by 52.1% to $11.9 million, mainly due to delays in receiving tender contracts from Oil Marketing Companies and a shift from cost-plus to fixed-price tenders, resulting in a 54% reduction in biodiesel sales volume (9.4 thousand metric tons).
- Selling, General and Administrative (SG&A) expenses decreased by 38.0% to $7.3 million in Q2 2025, partly due to a one-time $3.6 million asset write-off in Q2 2024 and increased rental income from subleases.
- The company continues to carry a conclusion of substantial doubt about its ability to continue as a going concern over the next twelve months due to substantial debt and reliance on its senior secured lender.
- Current portion of long-term debt increased significantly to $247.6 million as of June 30, 2025, from $63.7 million at December 31, 2024.
Sentiment
Score: 3
Explanation: The company faces severe liquidity challenges, evidenced by a very low current ratio and a 'going concern' warning. While there's operational progress in some segments and strategic projects are advancing, the significant debt burden, reliance on lender discretion, and overall revenue decline present substantial financial risk. The narrowing net loss is a positive, but it's overshadowed by the underlying financial instability and increased current debt obligations.
Positives
- Net loss for Q2 2025 significantly narrowed to $23.4 million from $29.2 million in Q2 2024.
- California Dairy Renewable Natural Gas segment revenue increased by 90.9% due to an increased number of operating digesters and improved LCFS credit revenue.
- Gross profit in the California Dairy RNG segment increased substantially to $855 thousand in Q2 2025 from a loss of $136 thousand in Q2 2024.
- SG&A expenses decreased by 38.0% in Q2 2025, partly due to the absence of a prior year asset write-off and increased rental income.
- The Mechanical Vapor Recompression (MVR) system at the Keyes Plant is under construction, expected to reduce natural gas consumption by approximately 80% and lower carbon intensity, improving future margins.
- The company began earning Section 45Z tax credits for ethanol and RNG production effective January 1, 2025, with recent federal legislation expected to increase these credits and extend their term to five years.
- California Air Resource Board (CARB) approved provisional pathways for seven dairy locations, expected to increase LCFS credit revenue from biogas by about 100% starting Q3 2025.
- CARB's recently approved amendments to the LCFS regulation, effective July 1, 2025, are expected to reduce the oversupply of LCFS credits and lead to higher credit prices.
- The India Biodiesel business has been self-sustaining from a cash and liquidity perspective for several years and is expected to continue this trend.
- Progress continues on the Sustainable Aviation Fuel (SAF) and Renewable Diesel (RD) plant, with Use Permit, CEQA approvals, and Authority to Construct air permits already secured.
- Initial drilling for the Carbon Capture and Underground Sequestration (CCUS) facility's characterization well has been completed, with ongoing development activities.
Negatives
- Total revenues decreased by 21.5% for Q2 2025 compared to the prior year, primarily driven by significant declines in the India Biodiesel and California Ethanol segments.
- Gross loss increased by 85.8% for Q2 2025, indicating worsening profitability at the cost of goods sold level.
- India Biodiesel segment revenue decreased by 52.1% due to delays in tender contracts and unfavorable pricing changes, leading to a 117.9% decrease in gross profit for the segment.
- The average cost of feedstock for India Biodiesel increased by 28% to $1,165 per metric ton in Q2 2025.
- The current ratio significantly deteriorated to 0.06 at June 30, 2025, from 0.31 at December 31, 2024, indicating severe short-term liquidity challenges.
- Current portion of long-term debt increased substantially to $247.6 million at June 30, 2025, from $63.7 million at December 31, 2024, due to debt reclassification.
- The company does not currently generate positive cash flow from consolidated operations.
- Stockholders' deficit increased to $(289.3) million at June 30, 2025, from $(263.9) million at December 31, 2024.
- Net cash provided by financing activities decreased to $11.3 million for the six months ended June 30, 2025, from $18.7 million in the prior year period.
Risks
- Substantial accumulated debt and reliance on the senior lender (Third Eye Capital) for extensions and continued cooperation, with a significant portion of debt maturing in the next 12 months.
- The company does not currently generate positive cash flow from consolidated operations, requiring additional working capital to fund operations.
- Volatility in market prices for input costs (e.g., corn, natural gas, waste fats and oils) and product revenues (e.g., ethanol, WDG, biodiesel, LCFS credits, D3 RINs) can negatively impact margins and cash flow.
- Future amendments or accommodations from the senior lender are at their discretion, and failure to obtain extensions could lead to insufficient cash to pay debt when due.
- Material weaknesses in internal controls over financial reporting, specifically IT general controls and certain internal controls, were identified and are undergoing remediation.
- The company faces customer concentration risk, with J.D. Heiskell accounting for over 90% of California Ethanol segment sales, and a single customer for California Dairy RNG sales.
- Delays in receiving tender contracts and unfavorable pricing changes from government-owned Oil Marketing Companies (OMCs) in India can significantly impact India Biodiesel segment revenues and profitability.
Future Outlook
The company plans to continue optimizing operations at the Keyes Plant, including implementing a Mechanical Vapor Recompression (MVR) system by the first half of 2026 to reduce natural gas consumption and lower carbon intensity. It expects increased income from Section 45Z tax credits for both ethanol and RNG production, with recent federal legislation anticipated to enhance these credits and extend their term. The company intends to expand its California Dairy Renewable Natural Gas segment by constructing additional digesters, with the next set expected to begin producing biogas in Q3 2025, and anticipates increased LCFS credit revenue due to provisional pathway approvals and new CARB regulation amendments. In India, plans include expanding operations and a potential public stock offering of the India subsidiary. The company will continue to seek additional funding through equity sales, refinancing existing debt, and obtaining project-specific debt and equity for development projects.
Management Comments
- We are executing our mission by building a circular bioeconomy using agricultural products and waste to produce low carbon renewable fuels that create jobs, reduce greenhouse gas (GHG) emissions, and improve air quality.
- We have already begun procuring MVR equipment and expect it to be installed later this year and begin operating in the first half of 2026.
- We have agreements with a total of fifty dairies and are seeking to sign agreements with additional dairies.
- We believe the Kakinada Plant is one of the highest capacity biodiesel production facilities in India.
- We have hired a new executive team in India to help develop plans for additional growth of our India business and to execute on a potential public stock offering of our India subsidiary.
- Notably, our India business has been self-sustaining from a cash and liquidity perspective for several years, and we expect this to continue.
- Notwithstanding our plans to improve liquidity and these favorable recent events, the extent of our debt and reliance on our senior secured lender, along with expected near-term shortfalls in cash flow from operations, require us to continue to carry forward the conclusion that there is substantial doubt about our ability to continue as a going concern over the next twelve months.
Industry Context
Aemetis operates within the dynamic renewable fuels and bioeconomy sectors, focusing on low and negative carbon intensity products. The company's strategic initiatives, such as the development of Sustainable Aviation Fuel (SAF) and Carbon Capture and Underground Sequestration (CCUS) facilities, align with global trends towards decarbonization and the increasing demand for sustainable energy solutions. The emphasis on leveraging governmental carbon reduction incentives like LCFS, RINs, and Section 45Z tax credits reflects the industry's reliance on policy support to drive profitability and project viability. The expansion of dairy renewable natural gas (RNG) production addresses the growing need for waste-to-energy solutions and aligns with agricultural sustainability efforts. The challenges faced in the India Biodiesel segment, particularly with government tender processes, highlight the regulatory and market complexities inherent in international renewable energy markets.
Comparison to Industry Standards
- The filing does not provide specific comparable company data or global benchmarks to assess the results in the context of industry standards.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer (India) | NA | New executive team member (unnamed) | NA | Hired to help manage an expected IPO and develop plans for additional growth of the India business. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weaknesses | Identified material weaknesses over financial reporting, specifically IT general controls and certain internal controls over financial reporting, which were not effective. | As of December 31, 2024 (identified in 2024 10-K) | Likely to adversely affect the ability to record, process, summarize, and report financial information. Remediation plans are being executed. |
Legal Proceedings
- In April 2025, a broker previously engaged by Advanced BioEnergy initiated litigation against Aemetis, Inc. to collect $2.3 million (plus interest and fees) under a settlement agreement.
Related Party Transactions
- The company owes Eric McAfee (Chairman and CEO) and McAfee Capital LLC (owned by Mr. McAfee) $1.3 million as of June 30, 2025. This is for employment agreements, bonus awards, expense reimbursements, and guarantee fees related to guarantees of the company's indebtedness to Third Eye Capital.
Stakeholder Impact
- Shareholders: Potential dilution from ongoing equity sales, increased stockholders' deficit, and significant uncertainty due to the 'going concern' warning and substantial debt. However, progress on strategic projects and potential future tax credits could offer long-term value.
- Creditors (especially Third Eye Capital): High exposure due to substantial debt, with a significant portion becoming current. Continued reliance on their discretion for debt extensions. The Series A Preferred Unit redemption obligation by August 31, 2025, or conversion to a new credit agreement, directly impacts these stakeholders.
- Employees: Continued operations and expansion projects (e.g., new digesters, MVR, SAF/RD, CCUS) suggest ongoing employment opportunities, but the 'going concern' warning introduces job security uncertainty.
- Customers: Continued supply of ethanol, WDG, RNG, and biodiesel, with potential for increased supply from new digesters and improved product carbon intensity. Delays in India biodiesel tenders could affect OMC customers.
- Suppliers (e.g., J.D. Heiskell, dairy operators, Gemini Edibles and Fats India Private Limited): Continued business relationships, but payment terms and market volatility remain factors. J.D. Heiskell is a highly concentrated customer/supplier.
Next Steps
- Continue to operate the Keyes Plant and optimize operating parameters based on market conditions.
- Complete construction of the Mechanical Vapor Recompression (MVR) system at the Keyes Plant, expected to be operational in the first half of 2026.
- Monetize Section 45Z tax credits earned from ethanol and RNG production.
- Continue to build new dairy digesters, with the next set expected to begin producing biogas in the third quarter of 2025.
- Obtain more provisional LCFS pathways for operating dairies.
- Begin operating the company's own RNG fuel dispensing station in 2025.
- Continue to operate the Kakinada Plant to produce biodiesel and glycerin and sell to government-owned Oil Marketing Companies (OMCs).
- Develop plans for additional growth of the India business and execute on a potential public stock offering of the India subsidiary.
- Continue with engineering and other required development activities for the Sustainable Aviation Fuel (SAF) and Renewable Diesel (RD) production plant.
- Continue engineering, permitting, and other development activities for the Carbon Capture and Underground Sequestration (CCUS) facility's characterization well and permanent sequestration wells.
- Continue selling equity through the at-the-market stock registration.
- Seek additional funding through refinancing existing loan agreements, entering into additional debt agreements for specific projects, and obtaining project-specific equity and debt.
- Obtain additional debt from the current EB-5 Phase II offering.
- Execute remediation plans to address material weaknesses in internal controls over financial reporting.
Key Dates
| Date | Description |
|---|---|
| 2012-07-06 | Aemetis, Inc., AAFK, and AFK entered into an Amended and Restated Note Purchase Agreement with Third Eye Capital Corporation. |
| 2012-07-06 | Merger between Aemetis Facility Keyes, Inc. and Cilion, Inc., incurring a $5.0 million payment obligation to Cilion shareholders. |
| 2012-01-09 | AAFK entered into Note and Warrant Purchase Agreements with two accredited investors for Subordinated Notes. |
| 2016-03-31 | Board of Directors approved an Inducement Equity Plan. |
| 2018-12-20 | Aemetis Biogas LLC entered into a Series A Preferred Unit Purchase Agreement. |
| 2019-02-27 | Advanced BioEnergy, LP, and AEAF entered into an Amendment to the EB-5 Notes, modifying maturity dates. |
| 2021-01-01 | Signed a lease with an option to purchase the Riverbank Industrial Complex. |
| 2022-03-02 | Goodland Advanced Fuels, Inc. (GAFI) and Aemetis Carbon Capture, Inc. (ACCI) entered into an Amended and Restated Credit Agreement with Third Eye Capital. |
| 2022-07-01 | UBPL entered into an operating agreement with Gemini Edibles and Fats India Private Limited. |
| 2022-07-26 | Secunderabad Oils mentioned in context of India Biodiesel segment. |
| 2022-08-01 | Leo Edibles Fats Limited mentioned in context of India Biodiesel segment. |
| 2022-10-04 | Aemetis Biogas 1 LLC (AB1) entered into a Construction Loan Agreement. |
| 2023-05-16 | Entered into a new Revolving Notes Series B agreement with Third Eye Capital. |
| 2023-07-28 | Aemetis Biogas 2 LLC (AB2) entered into a Construction and Term Loan Agreement. |
| 2023-09-01 | Received Use Permit and California Environmental Quality Act (CEQA) approvals for the SAF/RD plant. |
| 2023-11-06 | UBPL entered into a short-term loan agreement with a trade partner. |
| 2023-11-13 | UBPL entered into a secured loan agreement with a trade partner. |
| 2023-12-22 | AB1 Construction Loan was refinanced and replaced with a term loan. |
| 2024-03-01 | Received Authority to Construct air permits for the SAF/RD plant. |
| 2024-07-01 | Broker initiated litigation against Aemetis, Inc. to collect $2.3 million (plus interest and fees) under a settlement agreement. |
| 2024-11-30 | Company's subsidiary Aemetis RNG Fuels 1 LLC (RNG1) entered into two installment note agreements for land acquisition. |
| 2024-12-31 | Current maturity date for Subordinated Notes. |
| 2025-01-01 | Keyes Plant and RNG production started earning Section 45Z tax credits. |
| 2025-04-01 | Maturity date for Third Eye Capital Term Notes, Revolving Credit Facility, Revenue Participation Term Notes, and Acquisition Term Notes. |
| 2025-04-30 | Effective date of the PUPA Ninth Amendment to Series A Preferred Unit Purchase Agreement. |
| 2025-05-07 | ABGL entered into the PUPA Ninth Amendment to Series A Preferred Unit Purchase Agreement. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-01 | CARB's recently approved amendments to the LCFS regulation became effective. |
| 2025-07-31 | Number of shares outstanding of Common Stock was 63,240,956 shares. |
| 2025-08-07 | Date of filing of the Quarterly Report on Form 10-Q. |
| 2025-08-15 | Monthly payments of principal and interest for AB2 Loan begin. |
| 2025-08-31 | Required redemption date for all outstanding Series A Preferred Units. |
| 2025-09-01 | If Series A Preferred Units are not redeemed, ABGL will enter into a credit agreement with Protair-X and Third Eye Capital. |
| 2025-10-31 | Forward purchase agreement for natural gas at a fixed price of $3.30 per MMBtu expires. |
| 2025-11-30 | Extended maturity date for UBPL secured and short-term loan agreements. |
| 2026-01-22 | Equal monthly payments of principal and interest for AB1 Term Loan begin. |
| 2026-03-01 | Maturity date for Third Eye Capital Carbon Revolving Line. |
| 2026-04-01 | Maturity date for Third Eye Capital Term Notes, Revolving Credit Facility, Revolving Notes Series B, Revenue Participation Term Notes, and Acquisition Term Notes. |
| 2026-08-31 | Maturity date of the potential credit agreement with Protair-X and Third Eye Capital if Series A Preferred Units are not redeemed. |
| 2042-12-22 | Maturity date for Aemetis Biogas 1 LLC Term Loan. |
| 2043-07-28 | Maturity date for Aemetis Biogas 2 LLC Construction and Term Loan. |
Recommendation
sellDespite a narrower net loss and progress on strategic projects, the company faces severe liquidity issues, evidenced by a current ratio of 0.06 and a 'going concern' warning. A substantial portion of debt has been reclassified to current liabilities, indicating significant near-term obligations that the company may struggle to meet without further lender cooperation or capital raises. While future tax credits and project expansions offer long-term potential, the immediate financial instability and high reliance on discretionary debt extensions present an unacceptably high risk for investors. The ongoing equity sales also suggest potential dilution. A seasoned investor would likely view the current financial position as highly precarious, warranting a 'sell' recommendation to mitigate risk.
Keywords
Renewable Natural Gas, Biofuels, Ethanol, Biodiesel, Sustainable Aviation Fuel, Renewable Diesel, Carbon Capture, LCFS Credits, RINs, Section 45Z Tax Credits, Dairy Digesters, SEC Filing, Quarterly Report, AMTX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.